VA Office of Research and Development Listed a New Clinical Trial to Study VA Aripiprazole vs Esketamine for Treatment-Resistant Depression (VAST-D II).
In: Contify Life Science News, 2022-09-26
Zeitungsartikel
Zugriff:
Titel: |
VA Office of Research and Development Listed a New Clinical Trial to Study VA Aripiprazole vs Esketamine for Treatment-Resistant Depression (VAST-D II).
|
---|---|
Zeitschrift: | Contify Life Science News, 2022-09-26 |
Veröffentlichung: | 2022 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|